Global Health Limited (Medanta) announced on April 27, 2026, that its Board of Directors has approved the execution of a Business Transfer Agreement (BTA) to acquire a 79-bedded cancer care hospital in Indore. This strategic move involves the acquisition of a business undertaking currently owned and operated by Asian Institute of Oncology Private Limited (AIOPL). The transaction, valued at Rs. 30 crores, also includes the assignment of a lease deed and the execution of a fresh lease for an additional 1,700 sq. ft. of space within the facility.

The acquisition targets a specialized facility strategically located just 500 meters from Medanta’s existing hospital in Indore, aiming to enable seamless integration and operational synergies. This 79-bedded hospital is primarily focused on providing advanced super-specialty oncology services and reported a turnover of Rs. 19.9 million for FY 2024-25. The deal is expected to be completed well before the long-stop date of September 30, 2026, subject to standard regulatory approvals related to ownership transfer.

Founded by world-renowned cardiovascular surgeon Dr. Naresh Trehan, Global Health Limited is a premier multi-specialty tertiary care provider in Northern and Eastern India. In early 2026, the company has been on an aggressive expansion path, recently approving a Rs. 322 crore medical college project and a Rs. 550 crore, 400-bed hospital in Varanasi. The network currently includes flagship facilities in Gurugram, Lucknow, Patna, and Indore, with a total existing capacity of 3,579 beds as of late 2025.

For the latest quarterly results of Q3 FY26 (ending December 2025), Medanta reported a record quarterly revenue of Rs. 1,121.05 crore, a 18.83% YoY increase. However, consolidated net profit for the quarter fell by 33.51% YoY to Rs. 95.02 crore, largely due to initial operating losses and depreciation from the new Noida facility and a one-time labor code impact of Rs. 36.6 crore. Notable institutional investors include the Ravi Kant Jaipuria group and various large mutual funds such as SBI Large Cap and Axis Large Cap.